SCHEMBL6250832

SCHEMBL6250832

O=C(O)CCN1CCC(OC(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 10/20 0.63
CHRM2 P08172 2/20 0.60
HTR1A P08908 2/20 0.60
ADRA2A P08913 2/20 0.60
CHRM1 P11229 2/20 0.60
DRD1 P21728 2/20 0.60
SLC6A2 P23975 2/20 0.60
ADRA1A P35348 2/20 0.60
DRD3 P35462 2/20 0.60
SLC6A3 Q01959 2/20 0.60
KCNH2 Q12809 2/20 0.60
LMNA P02545 2/20 0.60
NPC1 O15118 1/20 0.60
MLNR O43193 1/20 0.60
NR1I2 O75469 1/20 0.60
EGFR P00533 1/20 0.60
ERBB2 P04626 1/20 0.60
FYN P06241 1/20 0.60
CHRM4 P08173 1/20 0.60
ABCB1 P08183 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4255734 0.99 BCHE (0.62) BCHECHRM2HTR1AADRA2ACHRM1
SCHEMBL9353353 0.93 CHRM2 (0.57) BCHECHRM2HTR1AADRA2ACHRM1
SCHEMBL14282957 0.92 BCHE (0.67) BCHECHRM2HTR1AADRA2ACHRM1
Hydrochloric Acid SCHEMBL9352882 0.92 BCHE (0.64) BCHECHRM2HTR1AADRA2ACHRM1
Hydrochloric Acid SCHEMBL9353181 0.92 BCHE (0.64) BCHECHRM2HTR1AADRA2ACHRM1
Hydrochloric Acid SCHEMBL9353008 0.92 MAPK1 (0.56) BCHECHRM2HTR1AADRA2ACHRM1
SCHEMBL9353283 0.91 CHRM2 (0.55) BCHECHRM2HTR1AADRA2ACHRM1
Hydrochloric Acid SCHEMBL9353305 0.90 BCHE (0.68) BCHECHRM2HTR1AADRA2ACHRM1
Hydrochloric Acid SCHEMBL9352942 0.89 BCHE (0.56) BCHECHRM2HTR1AADRA2ACHRM1
Hydrochloric Acid SCHEMBL9357066 0.89 MAPK1 (0.54) BCHECHRM2HTR1AADRA2ACHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7355042-B2 Treatment of CNS disorders using CNS target modulators HYPNION, INC. (US) 2008-04-08 US disclosed
US-7355042-B2 Treatment of CNS disorders using CNS target modulators HYPNION, INC. (US) 2008-04-08 US disclosed
US-7317026-B2 Sleep disorders; side effect reduction ; antihistamine antagonist HYPNION, INC. (US) 2008-01-08 US disclosed
US-7317026-B2 Sleep disorders; side effect reduction ; antihistamine antagonist HYPNION, INC. (US) 2008-01-08 US disclosed
US-7189757-B2 Treatment of sleep disorders using CNS target modulators HYPNION, INC. (US) 2007-03-13 US disclosed
US-7189757-B2 Treatment of sleep disorders using CNS target modulators HYPNION, INC. (US) 2007-03-13 US disclosed
WO-2003032912-A9 TREATMENT OF CNS DISORDERS USING CNS TARGET MODULATORS HYPNION INC (US) 2005-01-06 WO disclosed
EP-0399414-B1 Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same HOKURIKU PHARMACEUTICAL (JP) 1994-09-21 EP disclosed
US-5153207-A Antihistamine and antiallergic agent HOKURIKU PHARMACEUTICAL CO., LTD. (JP) 1992-10-06 US disclosed
EP-0399414-A1 Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same HOKURIKU PHARMACEUTICAL CO., LTD. (JP) 1990-11-28 EP disclosed